These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21225052)

  • 1. Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation.
    Frey K; Zivanovic A; Schwager K; Neri D
    Integr Biol (Camb); 2011 Apr; 3(4):468-78. PubMed ID: 21225052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibody-based delivery of interleukin-12 to the tumor neovasculature eradicates murine models of cancer in combination with paclitaxel.
    Pasche N; Wulhfard S; Pretto F; Carugati E; Neri D
    Clin Cancer Res; 2012 Aug; 18(15):4092-103. PubMed ID: 22693354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis.
    Kaspar M; Trachsel E; Neri D
    Cancer Res; 2007 May; 67(10):4940-8. PubMed ID: 17510424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeting properties of novel immunocytokines based on murine IL1β and IL6.
    Hess C; Neri D
    Protein Eng Des Sel; 2014 Jun; 27(6):207-13. PubMed ID: 24795343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C; Gafner V; Villani ME; Borsi L; Berndt A; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2003 Jun; 63(12):3202-10. PubMed ID: 12810649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7.
    Pasche N; Woytschak J; Wulhfard S; Villa A; Frey K; Neri D
    J Biotechnol; 2011 Jun; 154(1):84-92. PubMed ID: 21527292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer.
    Hemmerle T; Neri D
    Int J Cancer; 2014 Jan; 134(2):467-77. PubMed ID: 23818211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The targeted delivery of IL17 to the mouse tumor neo-vasculature enhances angiogenesis but does not reduce tumor growth rate.
    Pasche N; Frey K; Neri D
    Angiogenesis; 2012 Mar; 15(1):165-9. PubMed ID: 22052195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo.
    Villa A; Trachsel E; Kaspar M; Schliemann C; Sommavilla R; Rybak JN; Rösli C; Borsi L; Neri D
    Int J Cancer; 2008 Jun; 122(11):2405-13. PubMed ID: 18271006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice.
    Nilsson F; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2001 Jan; 61(2):711-6. PubMed ID: 11212273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dose-dependent tumor targeting of antibody-IFNγ fusion proteins reveals an unexpected receptor-trapping mechanism in vivo.
    Hemmerle T; Neri D
    Cancer Immunol Res; 2014 Jun; 2(6):559-67. PubMed ID: 24795141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-targeting antibody-anticalin fusion proteins for in vivo pretargeting applications.
    Steiner M; Gutbrodt K; Krall N; Neri D
    Bioconjug Chem; 2013 Feb; 24(2):234-41. PubMed ID: 23350721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12.
    Sommavilla R; Pasche N; Trachsel E; Giovannoni L; Roesli C; Villa A; Neri D; Kaspar M
    Protein Eng Des Sel; 2010 Aug; 23(8):653-61. PubMed ID: 20551083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model.
    Schwager K; Bootz F; Imesch P; Kaspar M; Trachsel E; Neri D
    Hum Reprod; 2011 Sep; 26(9):2344-52. PubMed ID: 21705369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered vascular-targeting antibody-interferon-gamma fusion protein for cancer therapy.
    Ebbinghaus C; Ronca R; Kaspar M; Grabulovski D; Berndt A; Kosmehl H; Zardi L; Neri D
    Int J Cancer; 2005 Aug; 116(2):304-13. PubMed ID: 15800913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical evaluation of the tumor-targeting properties of bispecific antibodies based on quantitative biodistribution data.
    Hemmerle T; Wulhfard S; Neri D
    Protein Eng Des Sel; 2012 Dec; 25(12):851-4. PubMed ID: 22972762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of PD-L1 blockade with a potency-matched dual cytokine-antibody fusion protein leads to cancer eradication in BALB/c-derived tumors but not in other mouse strains.
    De Luca R; Neri D
    Cancer Immunol Immunother; 2018 Sep; 67(9):1381-1391. PubMed ID: 29971465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
    Li L; Wartchow CA; Danthi SN; Shen Z; Dechene N; Pease J; Choi HS; Doede T; Chu P; Ning S; Lee DY; Bednarski MD; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1215-27. PubMed ID: 15001266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix.
    Carnemolla B; Borsi L; Balza E; Castellani P; Meazza R; Berndt A; Ferrini S; Kosmehl H; Neri D; Zardi L
    Blood; 2002 Mar; 99(5):1659-65. PubMed ID: 11861281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.